- Home
- ADMA vs MSGS Comparison
ADMA vs MSGS Comparison
Compare ADMA & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- MSGS
- Stock Information
- Founded
- ADMA 2004
- MSGS 1879
- Country
- ADMA United States
- MSGS United States
- Employees
- ADMA N/A
- MSGS N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- MSGS Services-Misc. Amusement & Recreation
- Sector
- ADMA Health Care
- MSGS Consumer Discretionary
- Exchange
- ADMA Nasdaq
- MSGS Nasdaq
- Market Cap
- ADMA 5.1B
- MSGS 4.6B
- IPO Year
- ADMA N/A
- MSGS N/A
- Fundamental
- Price
- ADMA $17.74
- MSGS $203.17
- Analyst Decision
- ADMA Strong Buy
- MSGS Buy
- Analyst Count
- ADMA 4
- MSGS 5
- Target Price
- ADMA $24.25
- MSGS $252.60
- AVG Volume (30 Days)
- ADMA 2.7M
- MSGS 151.7K
- Earning Date
- ADMA 08-07-2025
- MSGS 08-12-2025
- Dividend Yield
- ADMA N/A
- MSGS N/A
- EPS Growth
- ADMA N/A
- MSGS N/A
- EPS
- ADMA 0.84
- MSGS 0.20
- Revenue
- ADMA $459,381,000.00
- MSGS $1,062,514,000.00
- Revenue This Year
- ADMA $23.35
- MSGS N/A
- Revenue Next Year
- ADMA $27.67
- MSGS $6.01
- P/E Ratio
- ADMA $21.27
- MSGS $1,015.61
- Revenue Growth
- ADMA 62.23
- MSGS 14.64
- 52 Week Low
- ADMA $10.21
- MSGS $173.26
- 52 Week High
- ADMA $25.67
- MSGS $237.99
- Technical
- Relative Strength Index (RSI)
- ADMA 32.83
- MSGS 66.31
- Support Level
- ADMA $20.42
- MSGS $186.21
- Resistance Level
- ADMA $22.37
- MSGS $193.71
- Average True Range (ATR)
- ADMA 0.88
- MSGS 3.41
- MACD
- ADMA -0.28
- MSGS 0.86
- Stochastic Oscillator
- ADMA 1.07
- MSGS 76.91
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.